Neuroone Medical Technologies (NMTC) Share-based Compensation (2017 - 2026)

Neuroone Medical Technologies has disclosed Share-based Compensation across 10 years of filings, most recently posting $342135.0 for Q1 2026.

• Quarterly Share-based Compensation rose 36.76% year-over-year to $342135.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 8.53% YoY) and the FY2025 annual result came in at $1.3 million, down 5.94% from the prior year.
• Share-based Compensation retreated to $342135.0 in Q1 2026, from $359255.0 in the prior quarter.
• Across five years, Share-based Compensation topped out at $359255.0 in Q4 2025 and bottomed at $232716.0 in Q1 2022.
• The 5-year median for Share-based Compensation is $308638.0 (2023), against an average of $303533.6.
• Year-over-year, Share-based Compensation slumped 70.92% in 2022 and surged 50.18% in 2024.
• Neuroone Medical Technologies' Share-based Compensation stood at $300181.0 in 2022, then rose by 2.82% to $308638.0 in 2023, then climbed by 9.91% to $339224.0 in 2024, then climbed by 5.9% to $359255.0 in 2025, then decreased by 4.77% to $342135.0 in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $342135.0, $359255.0, and $358560.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.